Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 322.30
-11.60 (-3.47%)
Aug 5, 2025, 4:59 PM CET
Sage Therapeutics Market Cap
Zealand Pharma has a market cap or net worth of 23.70 billion as of August 5, 2025. Its market cap has decreased by -60.81% in one year.
Market Cap
23.70B
Enterprise Value
15.55B
Revenue
55.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
$322.30
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 23.70B, an increase of 1,586.12%. That is a compound annual growth rate of 21.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 23.70B | -53.11% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | 8.77B | 3.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,370.78B |
| Coloplast | 133.61B |
| Genmab | 85.30B |
| Demant | 52.15B |
| ALK-Abelló | 41.80B |
| H. Lundbeck | 32.40B |
| Ambu A/S | 24.51B |
| Bavarian Nordic | 18.34B |